Bibliography
- Brenner MK , HeslopHE: Adoptive T-cell therapy of cancer.Curr. Opin. Immunol.22 , 251–257 (2010).
- Rosenberg SA , DudleyME: Adoptive cell therapy for the treatment of patients with metastatic melanoma.Curr. Opin. Immunol.21 , 233–240 (2009).
- Besser MJ , Shapira-FrommerR, TrevesAJ et al.: Clinical responses in a Phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.Clin. Cancer Res.16 , 2646–2655 (2010).
- DiGiusto DL , CooperLJ: Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.Cytotherapy9 , 613–629 (2007).
- Dudley ME , YangJC, SherryR et al.: Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.J. Clin. Oncol.26 , 5233–5239 (2008).
- Gattinoni L , FinkelsteinSE, KlebanoffCA et al.: Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.J. Exp. Med.202 , 907–912 (2005).
- Robbins PF , DudleyME, WunderlichJ et al.: Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.J. Immunol.173 , 7125–7130 (2004).
- Ly LV , SluijterM, VersluisM et al.: Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm.Cancer Res.70 , 8339–8346 (2010).
- Palmer DC , BalasubramaniamS, HanadaK et al.: Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.J. Immunol.173 , 7209–7216 (2004).
- Hawkins RE , GilhamDE, DebetsR et al.: Development of adoptive cell therapy for cancer: a clinical perspective.Hum. Gene Ther.21 , 665–672 (2010).
- Wallen H , ThompsonJA, ReillyJZ, RodmyreRM, CaoJ, Yee C: Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. PLoS One4 , E4749 (2009).
- Hunder NN , WallenH, CaoJ et al.: Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.N. Engl. J. Med.358 , 2698–2703 (2008).